pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
KPV
Inflammation
PharmaTher Holdings Ltd
0
catalysts
Preclinical
KQ-2512
Systemic Lupus Erythematosus
Novatim Immune Therapeutics (Zhejiang) Co Ltd
0
catalysts
Phase 1
KQB-548
Metastatic Colorectal Cancer
Kumquat Biosciences Inc
0
catalysts
Preclinical
KRMII-81
Epilepsy
← prev
page 101 of 231
next →
131
Pain
89
Neurology
1
EndeavourRx LLC
0
catalysts
Preclinical
KRSA-028
Alzheimer's Disease
Korsana Biosciences Inc
0
catalysts
Preclinical
KRZQ-028
Graves' Ophthalmopathy
Chongqing Kerun Biopharm R & D Co Ltd
0
catalysts
Preclinical
KRZQ-035
Glaucoma
Chongqing Kerun Biopharm R & D Co Ltd
0
catalysts
Phase 2
KSL-W
Dental Plaque
US Army Medical Research & Materiel Command
0
catalysts
Phase 1
KSP-1007
Ventilator Associated Pneumonia (VAP)
Sumitomo Pharma Co Ltd
0
catalysts
Phase 2
KSQ-001
Head And Neck Squamous Cell Carcinoma (HNSC)
KSQ Therapeutics Inc
0
catalysts
Phase 2
KSQ-004
Acral Lentiginous Melanoma
KSQ Therapeutics Inc
0
catalysts
Phase 1
KST-6051
Metastatic Colorectal Cancer
$KG
Kestrel Group Ltd
0
catalysts
Preclinical
KT-20610
Autism Spectrum Disorder (ASD)
Kingdom Therapeutics Ltd
0
catalysts
Phase 2
KT-621
Eosinophilic Asthma
$KYMR
Kymera Therapeutics, Inc.
0
catalysts
Phase 2
KTP-001
Lumbar Hernia/Bleichner's Hernia
Teijin Pharma Ltd
0
catalysts
Phase 1
KTX-2001
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
K36 Therapeutics Inc
0
catalysts
Phase 2
KUS-121
Retinal Artery Occlusion
Kyoto Drug Discovery & Development Co Ltd
0
catalysts
Phase 1
KY-0118
Colorectal Cancer
Shanghai Keyi Pharmaceutical Technology Co Ltd
0
catalysts
Preclinical
KY-0601
Colorectal Cancer
Novatim Immune Therapeutics (Zhejiang) Co Ltd
0
catalysts
Preclinical
KY-0901
Bile Duct Cancer (Cholangiocarcinoma)
Novatim Immune Therapeutics (Zhejiang) Co Ltd
0
catalysts
Marketed
Kcentra
Kcentra ((coagulation factor II (human) + coagulation factor VII (human) + coagulation factor IX (human) + coagulation factor X (human) + protein C (human) + protein S (human)))
Bleeding And Clotting Disorders
CSL Behring LLC
0
catalysts
Phase 2
Ketamir-2
Chemotherapy Induced Peripheral Neuropathy
Miralogx LLC
0
catalysts
Marketed
Kimyrsa
Kimyrsa (oritavancin [INN])
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
Melinta Therapeutics LLC
0
catalysts
Preclinical
Kindolor
Diabetic Neuropathy
Lohocla Research Corp
0
catalysts
Marketed
Klaron
Sulfacetamide Sodium Oceanside (sulfacetamide sodium)
Acne Vulgaris
Bausch Health Americas Inc
0
catalysts
Preclinical
Kuragenx
Neurotrophic Keratitis
Pandorum Technologies Pvt Ltd
0
catalysts
Phase 1
L-130
Generalized Anxiety Disorder (GAD)
Cynaptec Pharmaceuticals Inc
0
catalysts
Phase 2
L-Citrulline
Sickle Cell Disease With Vaso-Occlusive Crisis
Asklepion Pharmaceuticals LLC
0
catalysts
LACOSAMIDE ORAL SOLUTION
LACOSAMIDE ORAL SOLUTION (LACOSAMIDE ORAL SOLUTION)
ALKEM LABS LTD
0
catalysts
LACRISERT
LACRISERT (HYDROXYPROPYL CELLULOSE)
BAUSCH AND LOMB INC
0
catalysts
